Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12122)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2017 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Desbois AC, Cacoub P. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World J Gastroenterol 2017; 23(9): 1697-1711 [PMID: 28321170 DOI: 10.3748/wjg.v23.i9.1697] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i9/1697.htm |
| Number | Citing Articles |
| 1 |
Patrice Cacoub, Anne Claire Desbois, Cloe Comarmond, David Saadoun. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Gut 2018; 67(11): 2025 doi: 10.1136/gutjnl-2018-316234
|
| 2 |
Stella Compagnoni, Erica Maria Bruno, Giorgio Madonia, Marco Cannizzaro, Salvatore Madonia. Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched. World Journal of Gastroenterology 2021; 27(21): 2771-2783 doi: 10.3748/wjg.v27.i21.2771
|
| 3 |
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
|
| 4 |
Sebastiano Leone, Patrizia Lorenzini, Alessandro Cozzi-Lepri, Giancarlo Orofino, Dario Bernacchia, Antonella Castagna, Marianna Menozzi, Giovanni Guaraldi, Giordano Madeddu, Antonio Di Biagio, Massimo Puoti, Andrea Gori, Antonella d’Arminio Monforte. Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study. European Journal of Clinical Microbiology & Infectious Diseases 2019; 38(10): 1857 doi: 10.1007/s10096-019-03618-8
|
| 5 |
Marina Angel, Yelena Petrosyan, Mary-Anne Doyle, Curtis Cooper. HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01198-x
|
| 6 |
Yannick Chibinda Birato, Tony Akilimali Shindano, Daudi Cinyabuuma, Ciza Abel, Cikomola Justin Chiruza, Andre N. H. Bulabula. Seroprevalence and associated risk factors of hepatitis C infection among diabetic patients in South‐Kivu, Eastern Democratic Republic of the Congo: A cross‐sectional study. Health Science Reports 2023; 6(8) doi: 10.1002/hsr2.1504
|
| 7 |
Man Yuan, Juan Zhou, Lingyao Du, Libo Yan, Hong Tang. Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58786-x
|
| 8 |
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infection. World Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
|
| 9 |
Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi. Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease. Nefrología (English Edition) 2020; 40(1): 46 doi: 10.1016/j.nefroe.2019.03.014
|
| 10 |
Yangbo Xi, Dongping Chen, Zhihui Dong, Hingcheung Lam, Jiading He, Keyi Du, Can Chen, Jun Guo, Jianmin Xiao. RNA Sequencing of Cardiac in a Rat Model Uncovers Potential Target LncRNA of Diabetic Cardiomyopathy. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.848364
|
| 11 |
Muneerah Hamad Aldubaie, Prarthana M. Suryavamshi, Uma M. Irfan, Hamad A. Al-Hamed, Turki Abdullah Almogbel, Ahmad Almatroudi, Faris Alrumaihi, Khaled Allemailem. Prevalence of Hepatitis C Viral Infection among Diabetes Mellitus Patients in Qassim Region, Saudi Arabia. Journal of Pure and Applied Microbiology 2023; 17(3): 1722 doi: 10.22207/JPAM.17.3.37
|
| 12 |
Nahum Méndez-Sánchez, Carlos E. Coronel-Castillo, Mariana Michelle Ramírez-Mejía. Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals. Pathogens 2024; 13(4): 339 doi: 10.3390/pathogens13040339
|
| 13 |
Raoni Freitas Carvalho, Ajax Mercês Atta, Isabela Silva de Oliveira, Taciana Pereira Sant’Ana Santos, João Pedro A. Santos, Maria Isabel Schinoni, Maria Luiza Brito de Sousa-Atta. Adiponectin levels and insulin resistance among patients with chronic hepatitis C. Acta Tropica 2018; 178: 258 doi: 10.1016/j.actatropica.2017.12.004
|
| 14 |
Cliviany Borges da Silva, Diego Alves Vieira, Luisa Freitas de Melo, Anna Luiza Soares Chagas, Adriana Dias Gomes, César Lúcio Lopes de Faria Jr, Rosângela Teixeira, Dulciene Maria de Magalhães Queiroz, Gifone Aguiar Rocha, Maria Marta Sarquis Soares, Juliana Maria Trindade Bezerra, Luciana Diniz Silva. Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus. World Journal of Hepatology 2020; 12(4): 137-148 doi: 10.4254/wjh.v12.i4.137
|
| 15 |
Dilruba Garashova, İlker İnanç Balkan, Reşat Özaras, Mert Ahmet Kuşkucu, Ayşenur Özdil, Khalis Mustafayev, Sibel Yıldız Kaya, Rıdvan Karaali, Bilgül Mete, Gökhan Aygün, Neşe Saltoğlu, Ömer Fehmi Tabak. Early Viral Kinetics in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals. Viral Hepatitis Journal 2023; 29(3): 101 doi: 10.4274/vhd.galenos.2023.2023-12-1
|
| 16 |
Preetha Rajkumar, Alok Kumar Dwivedi, Christopher Alfred Dodoo, Navkiran Kaur Shokar, Jennifer Salinas, Rajkumar Lakshmanaswamy. The association between metabolic syndrome and Hepatitis C virus infection in the United States. Cancer Causes & Control 2020; 31(6): 569 doi: 10.1007/s10552-020-01300-5
|
| 17 |
Ahmed Nagaty, Ekram W. Abd El-Wahab, Tatsuo Kanda. Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt. PLOS ONE 2017; 12(10): e0184654 doi: 10.1371/journal.pone.0184654
|
| 18 |
Sanjaya K. Satapathy, Kiran Joglekar, Miklos Z. Molnar, Bilal Ali, Humberto C. Gonzalez, Jason M. Vanatta, James D. Eason, Satheesh P. Nair. Achieving Sustained Virological Response in Liver Transplant Recipients With Hepatitis C Decreases Risk of Decline in Renal Function. Liver Transplantation 2018; 24(8): 1040 doi: 10.1002/lt.25059
|
| 19 |
Miika Vuorinen, Ville T. Männistö, Veikko Salomaa, Annie Britton, Antti Jula, Satu Männistö, Annamari Lundqvist, Markus Perola, Fredrik Åberg. Attribution of diabetes to the development of severe liver disease in the general population. Liver International 2022; 42(10): 2186 doi: 10.1111/liv.15296
|
| 20 |
Parimala Narne. Impaired insulin exocytosis in chronic hepatitis C infection: contributory role of p38δ MAPK–protein kinase D–golgi complex axis. Clinical Science 2020; 134(12): 1449 doi: 10.1042/CS20200686
|
| 21 |
Riccardo NEVOLA, Carlo ACIERNO, Pia C. PAFUNDI, Luigi E. ADINOLFI. Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07129-3
|
| 22 |
Chun-Hsiang Wang, Shih-Fang Ou, Yuan-Tsung Tseng. Long-term impact of certain coexisting extrahepatic unisystem and multisystem manifestations on trends in incidence of liver cirrhosis in treatment-naïve patients with chronic hepatitis C: A nested case-control study. Medicine 2022; 101(29): e29697 doi: 10.1097/MD.0000000000029697
|
| 23 |
Susanna Naggie, Marzena Swiderska-Syn, Steve Choi, Sam Lusk, Audrey Lan, Guido Ferrari, Wing-Kin Syn, Cynthia D Guy, Anna Mae Diehl. Markers of Tissue Repair and Cellular Aging Are Increased in the Liver Tissue of Patients With HIV Infection Regardless of Presence of HCV Coinfection. Open Forum Infectious Diseases 2018; 5(7) doi: 10.1093/ofid/ofy138
|
| 24 |
Luigi Elio Adinolf, Ira Jacobson, Mark Bondin, Patrice Cacoub. Expert Opinion on Managing Chronic HCV Infection in Patients with Type 2 Diabetes Mellitus. Antiviral Therapy 2018; 23(1_suppl): 11 doi: 10.3851/IMP3255
|
| 25 |
Emad Samaan, Shahera El-Etreby, Aimun Ahmed, Fatma El-Husseini, Alaa Sabry. The nature and prognosis of renal diseases in chronic hepatitis-C-infected diabetic Egyptian patients: The role of renal biopsy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022; 16(1): 102368 doi: 10.1016/j.dsx.2021.102368
|
| 26 |
Abdullah Awadh, Ziyad Badri, Nayef Alansari, Ahmed Alkhiri, Hussein Baharoon, Abdelulah Niaz, Alaa Al‐Kathiri, Enas Ghulam, Mohammad Khan. Effects of comorbid conditions and prescribed chronic medications on the treatment plan for chronic hepatitis C infection: A cross‐sectional retrospective study. Health Science Reports 2024; 7(5) doi: 10.1002/hsr2.2055
|
| 27 |
Ntethelelo Sibiya, Nomusa Mzimela, Bonisiwe Mbatha, Phikelelani Ngubane, Andile Khathi. The Insights on Why Diabetes Prevalence May Increase Amid or Post
COVID-19 Pandemic. Current Diabetes Reviews 2023; 19(4) doi: 10.2174/1573399818666220411122345
|
| 28 |
Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi. Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease. Nefrología 2020; 40(1): 46 doi: 10.1016/j.nefro.2019.03.013
|
| 29 |
Irene Cacciola, Giuseppina Russo, Roberto Filomia, Concetta Pitrone, Gaia Caccamo, Annalisa Giandalia, Angela Alibrandi, Maria Stella Franzè, Serena Porcari, Sergio Maimone, Carlo Saitta, Giovanni Squadrito, Giovanni Raimondo. Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis. Liver International 2021; 41(9): 2059 doi: 10.1111/liv.14905
|
| 30 |
Adit Singhal, Aniruddh Agrawal, Jun Ling. Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs. Journal of Cellular and Molecular Medicine 2018; 22(4): 2071 doi: 10.1111/jcmm.13553
|
| 31 |
Oleksandra Ya. Pryshliak, Larysa Ye. Kovalchuk, Oleksandra V. Marynchak, Oleksandr P. Boichuk, Ihor H. Hryzhak, Oksana Ye. Kondryn, Valentyna F. Piuryk. FUNCTIONAL STATE OF NEUTROPHIC GRANULOCYTES’ GENOME OF THE PERIPHERAL BLOOD IN PATIENTS WITH CHRONIC HEPATITIS C WITH CONCOMITANT DIABETES MELLITUS TYPE II. Wiadomości Lekarskie 2020; 73(8): 1671 doi: 10.36740/WLek202008116
|
| 32 |
Nang Thu Thu Kyaw, Srinath Satyanarayana, Anthony D Harries, Ajay M V Kumar, Khine Wut Yee Kyaw, Khaing Hnin Phyo, Matthew J Hayat, Kenneth G Castro, Matthew J Magee. Increased All-cause Mortality in People With HIV and Comorbidities: Hepatitis B and C Virus Seropositivity and Hyperglycemia in Myanmar, 2005–2017. Open Forum Infectious Diseases 2023; 10(1) doi: 10.1093/ofid/ofac672
|
| 33 |
Francesco Paolo Russo, Alberto Zanetto, Martina Gambato, Ilaria Bortoluzzi, Ramona Al Zoairy, Enrica Franceschet, Federica De Marchi, Luca Marzi, Erica Nicola Lynch, Annarosa Floreani, Fabio Farinati, Benedikt Schaefer, Patrizia Burra, Heinz Zoller, Andrea Mega. Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistance. Journal of Viral Hepatitis 2020; 27(2): 188 doi: 10.1111/jvh.13215
|
| 34 |
Ekram W. Abd El-Wahab, Hesham AK. Ayoub, Aziza A. Shorbila, Ashraf Mikheal, Mohamed Fadl, Amira M. Kotkat. Noninvasive biomarkers predict improvement in liver fibrosis after successful generic DAAs based therapy of chronic hepatitis C in Egypt. Clinical Epidemiology and Global Health 2020; 8(4): 1177 doi: 10.1016/j.cegh.2020.04.011
|
| 35 |
Patrick Kwabena Oduro, Xianxian Zheng, Jinna Wei, Yanze Yang, Yuefei Wang, Han Zhang, Erwei Liu, Xiumei Gao, Mei Du, Qilong Wang. The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. Acta Pharmaceutica Sinica B 2022; 12(1): 50 doi: 10.1016/j.apsb.2021.05.011
|
| 36 |
Jennifer Andres, Michael Barros, Michael Arutunian, Huaqing Zhao. Treatment of Hepatitis C Virus and Long-Term Effect on Glycemic Control. Journal of Managed Care & Specialty Pharmacy 2020; 26(6): 775 doi: 10.18553/jmcp.2020.26.6.775
|
| 37 |
Yu Zhou, Wenhuo Xie, Chenhua Zheng, Libin Liu, Zhou Chen, Xiaolu Wang. Hypoglycemia associated with direct‐acting anti‐hepatitis C virus drugs: An epidemiologic surveillance study of the FDA adverse event reporting system (FAERS). Clinical Endocrinology 2022; 96(5): 690 doi: 10.1111/cen.14660
|
| 38 |
A. Provoost, M. Dramé, L. Cotte, L. Cuzin, R. Garraffo, D. Rey, F. Raffi, I. Poizot‐Martin, P. Pugliese, F. Bani‐Sadr. Risk of diabetes in HIV‐infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort. Alimentary Pharmacology & Therapeutics 2018; 48(3): 281 doi: 10.1111/apt.14812
|
| 39 |
Andrea Pascual-Oliver, Diego Casas-Deza, Carmen Yagüe-Caballero, Jose M. Arbones-Mainar, Vanesa Bernal-Monterde. Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication. Pathogens 2024; 13(4): 278 doi: 10.3390/pathogens13040278
|
| 40 |
Szilárd Váncsa, Dávid Németh, Péter Hegyi, Zsolt Szakács, Ádám Farkas, Szabolcs Kiss, Péter Jenő Hegyi, Anna Kanjo, Patrícia Sarlós, Bálint Erőss, Gabriella Pár. Diabetes Mellitus Increases the Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy: Systematic Review and Meta-Analysis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.744512
|
| 41 |
Jinmin Jung, Jae Hyun Kwon, Gi-Won Song, Eun-Young Tak, Vavara A. Kirchner, Sung-Gyu Lee. Pre-emptive Treatment of HCV after Living Donor Liver Transplantation with Direct-Acting Antiviral Agents. Journal of Gastrointestinal Surgery 2018; 22(8): 1334 doi: 10.1007/s11605-018-3779-9
|
| 42 |
Wael A H Hegazy, Azza A H Rajab, Amr S Abu Lila, Hisham A Abbas. Anti-diabetics and antimicrobials: Harmony of mutual interplay. World Journal of Diabetes 2021; 12(11): 1832-1855 doi: 10.4239/wjd.v12.i11.1832
|
| 43 |
Anne Claire Desbois, Patrice Cacoub. Hepatitis C: Care and Treatment. 2021; : 21 doi: 10.1007/978-3-030-67762-6_2
|
| 44 |
Halima H. Al-Shuaili, Said A. Al-Busafi, Khalid Al-Naamani, Zakariya Al-Naamani. Predictors of survival among patients with chronic hepatitis C at a tertiary care center in Oman. Saudi Journal of Gastroenterology 2024; 30(1): 45 doi: 10.4103/sjg.sjg_201_23
|
| 45 |
Li-Xia Qiu, Ya-Li Liu, Wei Lin, Yi-Rong Liu, Hai-Bin Yu, Xin-Xin Wang, Ya-Meng Sun, Rong-Hua Jin, Zhong-Jie Hu, Jing Zhang. Liver stiffness measurement is a potent predictor of histological fibrosis regression after hepatitis C virus clearance. European Journal of Gastroenterology & Hepatology 2021; 33(4): 547 doi: 10.1097/MEG.0000000000001749
|
| 46 |
Nabeel Alzahrani. Hepatitis C virus, insulin resistance, and diabetes: A review. Microbiology and Immunology 2022; 66(10): 453 doi: 10.1111/1348-0421.13023
|
| 47 |
Masafumi Ono, Koji Fujita, Kiyoyuki Kobayashi, Tsutomu Masaki. Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma. Hepatology Research 2023; 53(7): 579 doi: 10.1111/hepr.13912
|
| 48 |
Xu Li, Le Wang, Pujun Gao. Chronic hepatitis C virus infection. Medicine 2019; 98(39): e17300 doi: 10.1097/MD.0000000000017300
|
| 49 |
Stephanie Klein, Jean-François Dufour. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Hepatic Oncology 2017; 4(3): 83 doi: 10.2217/hep-2017-0013
|
| 50 |
Juli Bai, Feng Liu. The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism. Diabetes 2019; 68(6): 1099 doi: 10.2337/dbi18-0052
|
| 51 |
Michele Colaci, Lorenzo Malatino, Alessandro Antonelli, Poupak Fallahi, Dilia Giuggioli, Clodoveo Ferri. Endocrine disorders associated with hepatitis C virus chronic infection. Reviews in Endocrine and Metabolic Disorders 2018; 19(4): 397 doi: 10.1007/s11154-018-9475-y
|
| 52 |
Zeynep Altın, Gülden Diniz, Ayfer Çolak, Betül Koyuncu, Serhat Özer, Fatih Aslan, Belkıs Ünsal. Influence of pegylated interferon and ribavirin on insulin resistance and metabolic factors in chronic hepatitis C. Turkish Journal of Biochemistry 2019; 44(2): 170 doi: 10.1515/tjb-2018-0163
|
| 53 |
Pierluca Piselli, Diego Serraino, Mario Fusco, Enrico Girardi, Angelo Pirozzi, Federica Toffolutti, Claudia Cimaglia, Martina Taborelli, Mariarosaria Capobianchi, Fabrizio Carletti, Anna R. Garbuglia, Giuseppe Ippolito, Paola Scognamiglio, Pietro Di Cicco, Letizia Gigli, Silvana Russospena, Raffaele Palombino, Chiara Panato, Veronica Mattioli, Luigino Dal Maso. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06336-9
|
| 54 |
Maria Nițescu, Cristina Vâjâitu, Oana Săndulescu, Adrian Streinu-Cercel, Daniela Pițigoi, Liliana Lucia Preoțescu, Anca Streinu-Cercel. Non-invasive quantification of liver fibrosis regression following successful treatment of chronic hepatitis C with direct acting antivirals. Revista Romana de Medicina de Laborator 2017; 25(4): 355 doi: 10.1515/rrlm-2017-0030
|
| 55 |
Sintayehu Ambachew, Setegn Eshetie, Demeke Geremew, Aklilu Endalamaw, Mulugeta Melku. Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis. Systematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-0976-x
|
| 56 |
Nobuhiro Hattori, Hiroki Ikeda, Tsunamasa Watanabe, Yosuke Satta, Takuya Ehira, Tatsuya Suzuki, Hirofumi Kiyokawa, Kazunari Nakahara, Hideaki Takahashi, Kotaro Matsunaga, Nobuyuki Matsumoto, Hiroshi Yasuda, Michihiro Suzuki, Fumio Itoh, Keisuke Tateishi. Risk factors for liver‐related mortality of patients with hepatitis C virus after sustained virologic response to direct‐acting antiviral agents. JGH Open 2022; 6(10): 685 doi: 10.1002/jgh3.12805
|
| 57 |
Shen-Shong Chang, Hsiao-Yun Hu, Yu-Chin Chen, Yung-Feng Yen, Nicole Huang. Late hepatitis C virus diagnosis among patients with newly diagnosed hepatocellular carcinoma: a case–control study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02504-6
|
| 58 |
Steven Flamm. Chronic hepatitis C virus infection: Everyone should be treated. Clinical Liver Disease 2017; 10(3): 72 doi: 10.1002/cld.658
|
| 59 |
Chun-Han Cheng, Chia-Ying Chu, Huan-Lin Chen, I-Tsung Lin, Chia-Hsien Wu, Yuan-Kai Lee, Ming-Jong Bair. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients. Frontiers in Endocrinology 2022; 12 doi: 10.3389/fendo.2021.799382
|
| 60 |
Tarun Pant, Anuradha Dhanasekaran, Xiaowen Bai, Ming Zhao, Edward B. Thorp, Joseph M. Forbess, Zeljko J. Bosnjak, Zhi-Dong Ge. Genome-wide differential expression profiling of lncRNAs and mRNAs associated with early diabetic cardiomyopathy. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-51872-9
|
| 61 |
Matt Driedger, Chrissi Galanakis, Mary-Anne Doyle, Curtis L. Cooper. Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieu. European Journal of Gastroenterology & Hepatology 2019; 31(2): 260 doi: 10.1097/MEG.0000000000001292
|
| 62 |
Robert B. Hood, William C. Miller, Abigail Shoben, Randall E. Harris, Alison H. Norris, Gbenga Olorunfemi. Maternal hepatitis C virus infection and three adverse maternal outcomes in the United States. PLOS ONE 2023; 18(10): e0291994 doi: 10.1371/journal.pone.0291994
|
| 63 |
Alaa Badawi, Giancarlo Di Giuseppe, Alind Gupta, Abbey Poirier, Paul Arora. Bayesian network modelling study to identify factors influencing the risk of cardiovascular disease in Canadian adults with hepatitis C virus infection. BMJ Open 2020; 10(5): e035867 doi: 10.1136/bmjopen-2019-035867
|
| 64 |
Evangelista Sagnelli, Caterina Sagnelli, Antonio Russo, Mariantonietta Pisaturo, Clarissa Camaioni, Roberta Astorri, Nicola Coppola. Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology 2020; 1323: 115 doi: 10.1007/5584_2020_604
|
| 65 |
Keisuke Miyoshi, Masahiro Tanabe, Kenichiro Ihara, Masaya Tanabe, Mayumi Higashi, Koji Narikiyo, Yosuke Kawano, Atsuo Inoue, Katsuyoshi Ito. Dual-Source Contrast-Enhanced Multiphasic CT of the Liver Using Low Voltage (70 kVp): Feasibility of a Reduced Radiation Dose and a 50% of Contrast Dose. Tomography 2023; 9(5): 1568 doi: 10.3390/tomography9050125
|
| 66 |
Xu Li, Yang Gao, Hongqin Xu, Jie Hou, Pujun Gao. Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09825-7
|
| 67 |
Blake A. Niccum, Jonathan G. Stine, Javelle A. Wynter, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 Diabetes. Clinical Diabetes 2020; 38(1): 40 doi: 10.2337/cd18-0112
|
| 68 |
Tien S Dong, Elizabeth S Aby, Jihane N Benhammou, Jenna Kawamoto, Steven-Huy Han, Folasade P May, Joseph R Pisegna. Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c. World Journal of Hepatology 2018; 10(9): 612-621 doi: 10.4254/wjh.v10.i9.612
|
| 69 |
Sylvia Drazilova, Martin Janicko, Lubomir Skladany, Pavol Kristian, Marian Oltman, Maria Szantova, Dusan Krkoska, Eva Mazuchova, Lubica Piesecka, Veronika Vahalova, Marek Rac, Ivan Schreter, Ladislav Virag, Tomas Koller, Adriana Liptakova, Miriam Ondrasova, Peter Jarcuska. Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6095097
|
| 70 |
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology 2022; 12(1): 23 doi: 10.3390/biology12010023
|
| 71 |
Dunya Tomic, Jonathan E. Shaw, Dianna J. Magliano. The burden and risks of emerging complications of diabetes mellitus. Nature Reviews Endocrinology 2022; 18(9): 525 doi: 10.1038/s41574-022-00690-7
|
| 72 |
Shintaro Ichikawa, Utaroh Motosugi, Tatsuya Shimizu, Marie Luise Kromrey, Yoshihito Aikawa, Daiki Tamada, Hiroshi Onishi. Diagnostic performance and image quality of low-tube voltage and low-contrast medium dose protocol with hybrid iterative reconstruction for hepatic dynamic CT. The British Journal of Radiology 2021; 94(1128) doi: 10.1259/bjr.20210601
|
| 73 |
Chuanhai Zhang, Jingjing Wang, Hanlin Zhang, Shunai Liu, Hyuek Jong Lee, Wanzhu Jin, Jun Cheng. Hepatitis C virus core protein induces hepatic steatosis via Sirt1‐dependent pathway. Liver International 2018; 38(5): 803 doi: 10.1111/liv.13581
|
| 74 |
P. A. Beliy, K. R. Dudina, O. O. Znoyko, T. N. Markova, I. A. Morozova, N. P. Blokhina, E. A. Nurmukhametova, N. D. Yushchuk. Prevalence of chronic HCV infection in patients with type 2 diabetes mellitus in Russia. Diabetes mellitus 2022; 25(1): 4 doi: 10.14341/DM12847
|
| 75 |
Xu Li, Yuan Jiao, Yunlong Xing, Pujun Gao. Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/5308308
|